ARTICLE | Company News
Gilead, Verily seek to uncover immunological insights from Gilead trials
May 4, 2018 4:19 PM UTC
Gilead Sciences Inc. (NASDAQ:GILD) and the Verily Life Sciences LLC (South San Francisco, Calif.) subsidiary of Google parent company Alphabet Inc. (NASDAQ:GOOG) partnered to identify and characterize immunological and molecular drivers of rheumatoid arthritis, inflammatory bowel disease (IBD) and lupus-related diseases.
The partners said the collaboration could identify new targets by characterizing subtypes of inflammatory diseases and identify signatures of treatment response to help tailor treatments for specific subgroups of patients...